Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is shown on the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Removed the temporary government funding/status notice from the page; the study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    No additions or deletions detected for the page. The content and layout remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:16:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Updated operating-status notice and version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:49:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated contact details and updated revision to v3.1.0; removed old revision v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:48.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:53:24.000Z thumbnail image

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.